Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 10.36
-0.28 (-2.63%)
Apr 8, 2026, 3:00 PM CST
SHA:600267 Revenue
In the year 2025, Zhejiang Hisun Pharmaceutical had annual revenue of 10.55B CNY with 7.79% growth. Zhejiang Hisun Pharmaceutical had revenue of 2.63B in the quarter ending December 31, 2025, with 6.54% growth.
Revenue
10.55B
Revenue Growth
+2.03%
P/S Ratio
1.14
Revenue / Employee
1.32M
Employees
7,994
Market Cap
12.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.55B | 762.79M | 7.79% |
| Dec 31, 2024 | 9.79B | -586.22M | -5.65% |
| Dec 31, 2023 | 10.37B | -1.66B | -13.82% |
| Dec 31, 2022 | 12.04B | -99.78M | -0.82% |
| Dec 31, 2021 | 12.14B | 782.07M | 6.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition